AEGERION PHARMACEUTICALS INC's ticker is AEGR and the CUSIP is 00767E102. A total of 102 filers reported holding AEGERION PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $925,000 | +6.0% | 311,600 | -46.9% | 0.08% | -8.5% |
Q2 2016 | $873,000 | -55.7% | 586,400 | +10.1% | 0.08% | -58.8% |
Q1 2016 | $1,971,000 | -49.5% | 532,800 | +37.8% | 0.20% | -60.0% |
Q4 2015 | $3,904,000 | +343.6% | 386,600 | +496.6% | 0.50% | +336.0% |
Q3 2015 | $880,000 | -63.4% | 64,800 | -48.9% | 0.11% | -66.1% |
Q2 2015 | $2,405,000 | +226.3% | 126,800 | +1374.4% | 0.34% | +100.0% |
Q3 2013 | $737,000 | -11.8% | 8,600 | -34.8% | 0.17% | -25.0% |
Q2 2013 | $836,000 | – | 13,200 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ADVENT INTERNATIONAL, L.P. | 447,001 | $14,344,000 | 100.00% |
Broadfin Capital, LLC | 1,620,088 | $51,988,000 | 2.56% |
SCOPIA CAPITAL MANAGEMENT LP | 2,899,585 | $93,048,000 | 2.40% |
Tamarack Capital Management, LLC | 400,000 | $11,656,000 | 2.38% |
March Altus Capital Management LP | 199,037 | $6,387,000 | 2.34% |
PRICE MICHAEL F | 240,000 | $7,702,000 | 0.94% |
DELTEC ASSET MANAGEMENT LLC | 106,151 | $3,406,000 | 0.72% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 3,207,598 | $102,932,000 | 0.61% |
CLOUGH CAPITAL PARTNERS L P | 508,800 | $16,327,000 | 0.52% |
Catalyst Capital Advisors LLC | 86,500 | $2,776,000 | 0.45% |